MariMed Inc., a leading player in the cannabis industry, is headquartered in the United States and operates across several key regions, including Massachusetts, Maryland, and Illinois. Founded in 2017, the company has rapidly established itself as a pioneer in the cultivation, production, and distribution of high-quality cannabis products. Specialising in both medical and recreational cannabis, MariMed offers a diverse range of products, including edibles, oils, and flower, all designed to meet the unique needs of consumers. Their commitment to quality and innovation has earned them a strong market position, with notable achievements such as multiple award-winning products and a robust portfolio of licensed facilities. With a focus on sustainability and community engagement, MariMed Inc. continues to set industry standards, making it a trusted name in the evolving cannabis landscape.
How does MariMed Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MariMed Inc.'s score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MariMed Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, MariMed Inc. does not inherit any emissions data from a parent company, nor does it have any cascading climate initiatives from other organisations. This lack of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, it is essential for companies like MariMed Inc. to establish clear climate commitments and reduction targets to align with global sustainability goals. Without specific emissions data or targets, it remains challenging to assess their environmental impact or commitment to climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MariMed Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
